Author

Zixiang Wang

Institution: Affiliated Hospital of Chengde Medical College

Observed institutions: Capital Medical University, Chengde Medical University, Xuan Wu Hospital of the Capital Medical University, Affiliated Hospital of Chengde Medical College, Beijing Institute for Brain Disorders

ORCID: 0000-0002-8488-7539

Observed ORCID: 0000-0002-8488-7539

OpenAlex ID: A5066518893

The effect of neutrophil extracellular traps in venous thrombosis

2023 · Weiwei Li, Zixiang Wang, et al. · Thrombosis Journal · 34

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis

2022 · Weiwei Li, Yinxuan Pei, et al. · Frontiers in Oncology · 27

Clinical value of AKR1B10 in hepatocellular carcinoma: A systematic review and meta-analysis

2022 · Zixiang Wang, Yinxuan Pei, et al. · PLoS ONE · 21

Successful conversion therapy for unresectable hepatocellular carcinoma is getting closer: A systematic review and meta-analysis

2022 · Yinxuan Pei, Weiwei Li, et al. · Frontiers in Oncology · 16

Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis

2023 · Zheng Liao, Zixiang Wang, et al. · PLoS ONE · 13

High jugular bulb in patients with non‐thrombotic internal jugular venous and transverse sinus stenosis: Clues to pathogenesis

2023 · Zhongao Wang, Chaitu Dandu, et al. · CNS Neuroscience & Therapeutics · 3

Model construction and thrombolytic treatment of rat portal vein thrombosis

2024 · Zixiang Wang, Chenguang Su, et al. · PLoS ONE · 1

Comparison of Efficacy and Safety between Immune Checkpoint Inhibitors and Targeted Drugs in Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

2024 · Chenguang Su, Zheng Liao, et al. · Combinatorial Chemistry & High Throughput Screening

Works count: 8

Citation count: 115

H-index: 5

I10-index: 5